Stocks-SRPT-Sarepta Therapeutics Inc

SRPT Sarepta Therapeutics Inc

128.92 -4.85 (-3.63%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade
Stocks-SRPT-Sarepta Therapeutics Inc
SRPT Sarepta Therapeutics Inc
Trade

Sarepta Therapeutics Inc price

-5.96% Past Week
Created with Highcharts 4.2.7 /Highstock 4.2.7
Market Cap
12.29B
Day’s Range
126.60
-
133.80
52W Range
55.15
-
172.67
Volume (3M)
1.5M
Price-Earnings Ratio
318.71
Revenue
1.5B
Top Discussions
CRISPR-Tech
United Kingdom
about a month ago
Dear Investors, Here is your monthly update for July 2024 ✨ July 2024 was a month filled with news that impacted markets in various ways. Volatility was evident as global investors shifted from big tech to small-cap stocks. The Japanese yen appreciated significantly after the Bank of Japan raised... Show More
Like CommentShare
Nick009
United Arab Emirates
about a month ago
Content has been flagged as spam and reported by eToro users
NESTORRUBIANO
Colombia
2 months ago
Rebalancing an investment portfolio consists of readjusting the weight of the different assets that make it up, according to the evolution of the market and the profile of the investor. That is, adapt the investment to the changes that occur to obtain the highest profitability. It is normal that when... Show More
Like CommentShare
null
.
eToroInvestment
eToro
2 months ago
Edited
🔔 𝗚𝗼𝗼𝗱 𝗠𝗼𝗿𝗻𝗶𝗻𝗴 𝗘𝘂𝗿𝗼𝗽𝗲 🔔 🔹 The highlight of the day will be Chair Jerome Powell’s semi-annual testimony to the Senate Banking Committee. The Fed’s Michael Barr and Michelle Bowman will also speak, along with the ECB’s Piero Cipollone. 🔹 $SRPT (Sarepta Therapeutics Inc) will report... Show More
Like CommentShare
null
.
nikonalimov
Germany
3 months ago
$SRPT (Sarepta Therapeutics Inc) is the hype real or do we see sellout next few days?
undefined logo
SRPT
Sarepta Therapeutics Inc
128.65
-4.85 (-3.63%)
Trade
Like CommentShare
RonBrunner
Germany
3 months ago
$SRPT (Sarepta Therapeutics Inc) gained so much today, yet i lost money? how???
undefined logo
SRPT
Sarepta Therapeutics Inc
128.65
-4.85 (-3.63%)
Trade
Like CommentShare
etorous
eToro
3 months ago
📣 The Daily Breakdown from Bret Kenwell @Bretman, eToro's investment and Options Analyst 📣 🗓️ Monday’s TLDR — June 24, 2024 🤔 Bonds are breaking out. Could it be a second-half story? 🏀🚢 Earnings from Nike and Carnival are in focus this week. 🤖 Apple and Meta are reportedly in talks about... Show More
Like CommentShare
null
.
eToroInvestment
eToro
3 months ago
🔔 𝗚𝗼𝗼𝗱 𝗠𝗼𝗿𝗻𝗶𝗻𝗴 𝗘𝘂𝗿𝗼𝗽𝗲 🔔 🔷 Economic Events in Focus: Watch for the PCE data release on Friday, projecting slight growth. Other key metrics this week include consumer confidence, iFO, new home sales, and GDP. 🔹Earnings Watch: Major earnings reports from $FDX (FedEx Corporation),... Show More
Like CommentShare
2 of 4
1 reply
null
.
LucaBelgero
Italy
3 months ago
Giornata di mercato del 21/06/2024 ➡️Wall Street chiude quasi invariata: $DJ30 +0,04%, S&P500 -0,1%, Nasdaq -0,2%. Nvidia (-3,2%) scende per il secondo giorno consecutivo mentre Apple (-1%) ha rinviato sine die il lancio del suo sistema di intelligenza artificiale generativa nell'Unione Europea,... Show More Translate
Like CommentShare
null
.
DavidAlmeida1972
Portugal
3 months ago
$SRPT (Sarepta Therapeutics Inc) I just closed the trade at a profit of 25.7% on 21/06/2024 opened on 10/05/2024
undefined logo
SRPT
Sarepta Therapeutics Inc
128.65
-4.85 (-3.63%)
Trade
Like CommentShare

About Sarepta Therapeutics Inc

Sarepta Therapeutics, Inc. is a biopharmaceutical company that specialises in developing solutions for rare neuromuscular diseases. The company is a leader in the field of precision genetic medicine, with its core activities focused in gene therapy, gene editing, and RNA technologies. Sarepta Therapeutics was founded in 1980 under its original name of AntiVirals, Inc. It changed its areas of specialism, and its name, first to AVI BioPharma in 1997, before rebranding as Sarepta Therapeutics, Inc. in 2012. Operating globally, the company employs over 850 people and has offices in France, Germany, Ireland, Switzerland, and the UK, with its headquarters in Cambridge, Massachusetts. The genetic diseases that Sarepta Therapeutics focuses on include Duchenne muscular dystrophy, limb-girdle muscular dystrophy, mucopolysaccharidosis IIIA, and Charcot-Marie-Tooth disease. Sarepta Therapeutics has over 40 therapies in various stages of development. Current products include Exondys 51, Vyondys 53, and Amondys 45. Sarepta Therapeutics, Inc. trades using the ticker SRPT on the NASDAQ. The company partners with a range of companies, including AavantiBio, Inc., Dyno Therapeutics, Lysogene, and Roche. It also works closely with several universities, including Columbia University, Harvard University, and the University of Western Australia. Add SRPT stock to your eToro watchlist and stay up to date with all the latest news and stock value changes.
Douglas S. Ingram
CEO
1.3K
Employees
1980
Founded
Cambridge, Massachusetts, US
HQ
Show More
Med TechNASDAQ

ESG: A New Source of Insight

What is an ESG Score?
This number is a measure of a company’s exposure to environmental, social, and governance risks. Influencing factors include energy efficiency, safety, social policies, and more. Learn More
Powered by ESG Book
Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
46
Low
Industry 
Avg. 46 
38
Environment
47
Social
47
Governance
Business Involvement Flags
GMO
Companies engaged in plant and animal breeding, genetics and genomics, including animal and plant DNA testing services.
Powered by ESG Book

Analyst Forecast

Consensus
Strong Buy
Price Target
194.63
Based on 9 analysts who covered SRPT 

People Also Bought